In a report released today, Asthika Goonewardene from Truist Financial assigned a Buy rating to Legend Biotech (LEGN – Research Report).

Legend Biotech Corporation (NASDAQ:LEGN) Q3 2024 Earnings Call Transcript November 12, 2024 Operator: Ladies and gentlemen, ...

Detailed price information for Legend Biotech Corp ADR (LEGN-Q) from The Globe and Mail including charting and trades.

Detailed price information for Legend Biotech Corp ADR (LEGN-Q) from The Globe and Mail including charting and trades.

In a report released today, Sami Corwin from William Blair maintained a Hold rating on Legend Biotech (LEGN – Research Report). The ...

After losing some value lately, a hammer chart pattern has been formed for Legend Biotech (LEGN), indicating that the stock has found support. This, combined with an upward trend in earnings estimate ...

Legend Biotech Corp (NASDAQ:LEGN) is set to release its Q3 2024 earnings on Nov 12, 2024. The consensus estimate for Q3 2024 ...

On Friday, Legend Biotech Corp (LEGN) stock saw a decline, ending the day at $40.03 which represents a decrease of $-0.92 or -2.25% from the prior close of $40.95. The stock opened at $40.61 and ...

On Tuesday, Legend Biotech Corp (LEGN) stock saw a modest uptick, ending the day at $44.62 which represents a slight increase of $1.01 or 2.32% from the prior close of $43.61. The stock opened at $45 ...

A team of AI researchers and mathematicians affiliated with several institutions in the U.S. and the U.K. has developed a math benchmark that allows scientists to test the ability of AI systems to ...

Below is Validea's guru fundamental report for LEGEND BIOTECH CORP (ADR) (LEGN). Of the 22 guru strategies we follow, LEGN rates highest using our P/B Growth Investor model based on the published ...

On Friday, TD Cowen maintained a positive outlook on shares of Legend Biotech Corp. (NASDAQ:LEGN), reasserting a Buy rating and a $67.00 price target for the company's stock. The ...